Cardiac myocyte-specific overexpression of human GTP cyclohydrolase I protects against acute cardiac allograft rejection.
GTP cyclohydrolase I (GTPCH) is the rate-limiting enzyme for tetrahydrobiopterin (BH(4)) synthesis. Decreases in GTPCH activity and expression have been shown in late stages of acute cardiac rejection, suggesting a deficit in BH(4). We hypothesized that increasing intracellular levels of BH(4) by ca...
Main Authors: | Ionova, I, Vásquez-Vivar, J, Cooley, B, Khanna, A, Whitsett, J, Herrnreiter, A, Migrino, R, Ge, Z, Regner, K, Channon, K, Alp, N, Pieper, G |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
Decreased Cardiac Allograft Rejection in Mice Over-Expressing Human GTP Cyclohydrolase I.
by: Irina, I, et al.
Published: (2009) -
Cardiomyocyte-Targeted Overexpression of GTP Cyclohydrolase-1 Increases Myocyte Lusitropy and Reduces Superoxide Production
by: Carnicer, R, et al.
Published: (2010) -
GTP cyclohydrolase I expression, protein, and activity determine intracellular tetrahydrobiopterin levels, independent of GTP cyclohydrolase feedback regulatory protein expression.
by: Tatham, A, et al.
Published: (2009) -
Transgenic overexpression of GTP cyclohydrolase 1 in cardiomyocytes ameliorates post-infarction cardiac remodeling
by: Yanan Liu, et al.
Published: (2017-06-01) -
GTP cyclohydrolase I deficiency results in oxidative stress and pulmonary hypertension
by: Khoo, J, et al.
Published: (2004)